Icm Adx-2191
Primary Vitreoretinal Lymphoma
Aldeyra Therapeutics, Inc.Phase 3
—
Rating in progress
Icm Adx-2191 in Primary Vitreoretinal Lymphoma is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.
Methodology v0.2 · Active